PAG
KIN

Private Advisor Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Private Advisor Group’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$4K – 3819
2020
Q2 		$4K Buy
+1,000
New +$4.47K ﹤0.01% 3392

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Private Advisor Group's KIN Position: Q3 2020 in Review

Private Advisor Group sold out of Kindred Biosciences, Inc. (KIN) in Q3 2020, closing a stake of 1,000 shares — an estimated $4K sold.

Private Advisor Group first reported a position in KIN in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 77 funds tracked by Wall St. Rank hold KIN as of Q3 2020.

  • Private Advisor Group reported no remaining Kindred Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 1,000 Kindred Biosciences, Inc. shares in Q3 2020, an estimated $4K.
  • Private Advisor Group first reported a position in Kindred Biosciences, Inc. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Kindred Biosciences, Inc. position peaked at $4K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.